BIORA THERAPEUTICS INC (BIOR)

US74319F3055 - Common Stock

0.7297  -0.01 (-1.03%)

After market: 0.7003 -0.03 (-4.03%)

News Image
4 days ago - InvestorPlace

BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q1 2024

BIOR stock results show that Biora Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

News Image
4 days ago - BusinessInsider

BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biora Therapeutics (NASDAQ:BIOR) just reported results for the first quarter of...

News Image
4 days ago - Biora Therapeutics, Inc.

Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

Management will host conference call and webcast today, May 15, 2024, at 4:30 PM Eastern / 1:30 PM Pacific....

News Image
13 days ago - Biora Therapeutics, Inc.

Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update

The company’s management will host a webcast and conference call on Wednesday, May 15, 2024, after the close of financial markets....

News Image
a month ago - Biora Therapeutics, Inc.

Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technology

Claims cover key jet parameters for liquid jet delivery of a drug to the gastrointestinal tract

News Image
2 months ago - Biora Therapeutics, Inc.

Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development

All pharmacokinetic endpoints were achieved; all NaviCap™ devices performed as intended; no safety signals observed...

News Image
2 months ago - Biora Therapeutics, Inc.

Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery,...

News Image
2 months ago - InvestorPlace

BIOR Stock Earnings: Biora Therapeutics Misses EPS for Q4 2023

BIOR stock results show that Biora Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

News Image
2 months ago - BusinessInsider

BIOR Stock Earnings: Biora Therapeutics Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biora Therapeutics (NASDAQ:BIOR) just reported results for the fourth quarter o...

News Image
3 months ago - Biora Therapeutics, Inc.

Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposium

Dr. Ariella Kelman to participate in panel titled

News Image
4 months ago - Biora Therapeutics, Inc.

Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.

Biora will participate in a virtual fireside chat hosted by H.C. Wainwright & Co. on Monday, January 29, 2024 at 11:00 AM Eastern / 8:00 AM Pacific....

News Image
4 months ago - Biora Therapeutics, Inc.

Biora Therapeutics Provides Outlook for 2024

Multiple catalysts anticipated in 2024, including clinical study results for NaviCap™ Targeted Oral Delivery Platform and progress on pharma partnerships for BioJet™ Systemic Oral Delivery Platform

News Image
4 months ago - Biora Therapeutics, Inc.

Biora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600

SAD/MAD study to evaluate safety and PK/PD of BT-600 drug-device combination, including concentrations in colon tissue ...